User talk:Richardatlarge

Duplicate images uploaded
Thanks for uploading Image:Lindy.jpg. A machine-controlled robot account noticed that you uploaded the same image twice: as Image:Lindy.jpg and also as Image:Lindy.jpeg. The latter copy of the file has been marked for speedy deletion since it is redundant. If this sounds okay to you, there is no need for you to take any action.

This is an automated message- you have not upset or annoyed anyone. In the future, you may save yourself some confusion if you supply a meaningful file name and remember exactly which name you chose (file names are case sensitive, including the extension) so that you won't lose track of your uploads. For tips on good file naming, see Wikipedia's image use policy. If you have any questions about this notice, or feel that the deletion is inappropriate, please contact User:Staecker, who operates the robot account. Staeckerbot 10:02, 20 April 2007 (UTC)

WikiProject Pharmacology Collaboration of the Week
WikiProject Pharmacology is currently organizing a new Collaboration of the Week program, designed to bring drug and medication related articles up to featured status. We're currently soliciting nominations and/or voting on nominations for the first WP:RxCOTW, to begin on September 5, 2007. Please stop by the Pharmacology Collaboration of the Week page to participate! Thanks! Dr. Cash 17:53, 1 September 2007 (UTC)

Pharmacology Collaboration of the Week
Aspirin has been selected as this week's Pharmacology Collaboration of the Week! Please help us bring this article up to featured standards during the week. The goal is to nominate this at WP:FAC on September 10, 2007.

Also, please visitWP:RxCOTW to support other articles for the next COTW. Articles that have been nominated thus far include Doxorubicin, Paracetamol (in the lead with 4 support votes so far), Muscle relaxant, Ethanol, and Bufotenin.

In other news:


 * Bupropion has been promoted to featured status on August 31, 2007.


 * The WikiProject Pharmacology main page has been updated and overhauled, to make it easier to find things, as well as to highlight other goals and announcements for the project.


 * Garrondo is asking for individuals to help review Therapies for multiple sclerosis, as he is considering nominating this article for GA status.


 * Fvasconcellos notes that discussion is ongoing regarding the current wording of MEDMOS on including dosage information in drug articles. All input is welcome.

Dr. Cash 00:51, 5 September 2007 (UTC)

WikiProject Pharmacology Update
Here's a brief update in some of the recent developments of WikiProject Pharmacology!


 * Aspirin has just completed its two week run as the first Collaboration of the Week! Many thanks to those editors that contributed; the article got a lot of good work accomplished, and in particular, much work was done in fixing up the history section. It's still not quite "done" yet (is a wikipedia article really ever done?), but after two weeks I think it's more important to push onwards with the development of the new collaboration of the week program. I will be fixing up Aspirin in the next few days and possibly nominating it for either GA or FA status.


 * Muscle relaxant has been selected as the new Collaboration of the week until October 2, 2007! This article is currently rated as a "stub", so it's got quite a bit of work cut out for collaborators! Admittedly, featured status could be a long way off,... but still attainable! At the least, maybe we could at least get it up to meeting the Good article criteria? Please stop by the article and help improve it.


 * Resveratrol, having recently achieved GA status on August 16, 2007, is now making a run for featured status. This is quite a fascinating compound. If you can, please stop by its discussion page and leave comments in support of it.


 * Please remember that Wikipedia is not a forum for discussing or dispensing medical advice amongst users. Specifically, talk pages of articles should only be used to discuss improving the actual article in question. To help alleviate this situation, the template talkheader may be added to the top of talk pages, reminding users of the purpose of such pages. Additionally, unsigned comments and comments by anonymous users that are inappropriate may be removed from talk pages without being considered vandalism.


 * There was an interesting article on ZDNet last week about Hewlett Packard licensing its patented microneedle technology used in common inkjet printers to be used in transdermal patches to deliver a time-controlled release of drugs to patients. This information could be added to articles such as route of administration or drug delivery.

You are receiving this message because you are listed as one of the participants of WikiProject Pharmacology.

Dr. Cash 04:55, 19 September 2007 (UTC)

WikiProject Pharmacology Update
Here are a few updates in the realm of WikiProject Pharmacology:


 * The Pharmacology Collaboration of the Week has been changed to Collaboration of the Month, based on current participation levels. It is also more likely that articles collaborated on for one month are more likely to achieve featured quality than articles worked on for only a week or two.


 * The current Collaboration of the Month for November is Receptor antagonist. Please take a look at that article and contribute to it if you get a chance. Ideally, the article should adhere to the featured article criteria.


 * Therapies for multiple sclerosis is currently a featured article candidate. If you are familiar with the featured article criteria, please visit WP:FAC and review the article.


 * Anabolic steroid is the wikiproject's newest Featured Article, having been promoted on October 8, 2007.


 * Theobromine was delisted as a Good Article. The Peer review and GA reassessment discussions provide suggestions on improvement. Muscle relaxant was recently reviewed for Good Article status, but not promoted. Please see the full review full review here for details.

Dr. Cash 22:16, 31 October 2007 (UTC)

Alfred R. Lindesmith
Wanted to let you know as a courtesy that I removed the Category:American psychologists from the Lindesmith article. While Lindesmith made contributions to the field of social psychology, he did so as a sociologist. I had Lindesmith as a professor in the 1960s and got to know him personally. He was kind and congenial, with a voice a lot like that of Studs Terkel. I wanted to start this article myself, but I kept putting it off. Glad you got it launched. I'm not sure that I could do justice to the technical aspects of his work. --Cuppysfriend (talk) 17:58, 18 November 2008 (UTC)

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)
Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.

Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!

If you are stil active as a medical editor, come and sign up :)

Cheers, Ocaasit &#124; c 19:59, 16 June 2013 (UTC)

File permission problem with File:Alfred R. Lindesmith.jpg
Thanks for uploading File:Alfred R. Lindesmith.jpg, which you've attributed to http://wayback.archive.org/web/20070227104228/http://home.earthlink.net/~hsbecker/picturepage.html. I noticed that while you provided a valid copyright licensing tag, there is no proof that the creator of the file has agreed to release it under the given license.

If you are the copyright holder for this media entirely yourself but have previously published it elsewhere (especially online), please either
 * make a note permitting reuse under the CC-BY-SA or another acceptable free license (see this list) at the site of the original publication; or
 * Send an email from an address associated with the original publication to permissions-en@wikimedia.org, stating your ownership of the material and your intention to publish it under a free license. You can find a sample permission letter here. If you take this step, add OTRS pending to the file description page to prevent premature deletion.

If you did not create it entirely yourself, please ask the person who created the file to take one of the two steps listed above, or if the owner of the file has already given their permission to you via email, please forward that email to permissions-en@wikimedia.org.

If you believe the media meets the criteria at Non-free content, use a tag such as non-free fair use or one of the other tags listed at File copyright tags, and add a rationale justifying the file's use on the article or articles where it is included. See File copyright tags for the full list of copyright tags that you can use.

If you have uploaded other files, consider checking that you have provided evidence that their copyright owners have agreed to license their works under the tags you supplied, too. You can find a list of files you have created in [ your upload log]. Files lacking evidence of permission may be deleted one week after they have been tagged, as described on criteria for speedy deletion. You may wish to read Wikipedia's image use policy. If you have any questions please ask them at the Media copyright questions page. Thank you. Stefan2 (talk) 22:49, 17 January 2016 (UTC)

Your submission at Articles for creation: Richard DeGrandpre (April 25)
 Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reasons left by Crunchydillpickle were:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Richard DeGrandpre and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:Richard_DeGrandpre Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:Crunchydillpickle&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Richard_DeGrandpre reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

Crunchydillpickle🥒 (talk) 01:37, 25 April 2024 (UTC)